Gsk Share Discussion Threads

[pander45] 10/10/2024 13:32

Some peoples cup is half full even with a hole in the bottom. Odd.

[tradermichael] 10/10/2024 13:28

abdulla - it seems that your cup is always half empty when for others, theirs is half full ;o)

[abdullla] 10/10/2024 13:05

Nearly 40p down from the HIGH of today

[suetballs] 10/10/2024 12:57

Yep - we need to get the budget out of the way.
Confidence is knackered and Starmer & co haven't got a clue.
Suet

[dope007] 10/10/2024 12:46

Look at liontrust. Money is being pulled from the UK daily

[mj19] 10/10/2024 12:46

Well I guess that's the end of the litigation Can you offset the litigation costs against your tax liability?

[phda] 10/10/2024 12:29

Yes, should be a lot higher. I suspect a lot of short term traders may take profit but moving forward this is only going in one direction now the shadow of litigation has been removed.

[tradermichael] 10/10/2024 11:42

Why a "gamble on court cases"? (The litigation is virtually over and the price depression was a direct result of the Zantac debacle). The pipeline is strong and the time is long overdue to return to fundamentals. Target: 2000p.

[pierre oreilly] 10/10/2024 11:31

Feels more like a gamble on court cases rather than an investment in drugs. I think this has a long way to go to get it back to a drugs valuation.

[dr biotech] 10/10/2024 10:55

I think its a disgrace that we have to stump up such a huge amount as there is no proper evidence whatsoever that Zantac causes cancer. Having said that the settlement itself is pragmatic and is the right thing to do. Its way less than many predicted and it stops GSK having their name and reputation dragged through the mud in a never ended series of courts.

[geckotheglorious] 10/10/2024 10:28

Great settlement for GSK

$2.2bn

A bargain


"Worries had mounted over how many billions GSK might have to pay, with analyst estimates reaching $8 billion last year and even $45 billion in 2022.

That has weighed heavily on its share price, with tens of billions of dollars wiped off the market value of companies linked to the drug. Shares recovered as the cases were eventually settled. Bloomberg

[montyhedge] 10/10/2024 10:23

Yes now good value, investors hate uncertainty, now settled, good news.

[tradermichael] 10/10/2024 09:52

Even with today's settlement news and 6% jump in share price (so far), GSK continues to be seriously undervalued and remains an outstanding BUY.

[dplewis1] 10/10/2024 09:39

GSK's investment case has significantly improved following its settlement of liability cases related to its discontinued Zantac drug, Deutsche Bank analysts Emmanuel Papadakis and Niall Alexander say in a note. The resolve is a surprising and positive twist to the investment case as it came sooner than expected and should ease investors concerns that had weighed on the shares, they say. Even with the share boost following the news, the pharma giant still seems undervalued based on its projected earnings for 2025, they add.

[tradermichael] 10/10/2024 09:16

Anyone re-investing their GSK dividend (paid today)?

[tradermichael] 10/10/2024 09:00

In corporate news, GSK surged after agreeing to pay $2.2bn to settle about 80,000 Zantac lawsuits in the US.

In a statement released after the close of markets on Wednesday, the pharmaceuticals firm said it had reached an agreement with 10 firms who represent 93% of the Zantac (ranitidine) state court product liability cases pending against it in the US.

GSK also said it had agreed to pay $70m to resolve a whistleblower complaint by a laboratory called Valisure, which alleged that the pharmaceuticals company had defrauded the US government by concealing the cancer risks of heartburn drug Zantac for decades.

[mister md] 10/10/2024 08:54

+6% and a dividend paid out today...

[simon8] 10/10/2024 08:10

Indeed, looks like a positive view from market

[patientcapital] 10/10/2024 08:08

Opening USD4bn or so up seems to indicates market relief.

[simon8] 10/10/2024 07:44

What happened to the Delaware supreme court appeal, have I missed something? Not sure how price will react but only 15 mins to find out...

[waldron] 10/10/2024 06:29

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.

The British pharmaceutical giant said Wednesday that it had struck agreements with 10 plaintiff firms aimed at resolving 93%, or about 80,000, of pending Zantac lawsuits in the country for up to $2.2 billion.

Write to [e-mail]

[patientcapital] 09/10/2024 23:14

USD2.2bn seems a relative bargain compared with the 5 or so being speculated about a few months ago. On balance good news.

[dope007] 09/10/2024 21:28

It's the USA. Pay to settle or we drag you out for years for our own pockets, not the plaintiff.

[rikky72] 09/10/2024 21:25

Settlement of Zantac cases for up to $2.2 billion. I think this is wrong and the company has managed this really badly. I have sympathy with anyone with cancer but the 16 studies showed clearly that Zantac was not the cause. Despicable lawyers.